News
EMED Technologies Director of Clinical Affairs Alex Nikanorov shares the company’s approach to deciding which clinical ...
Donald Trump has promised to create a pro-AI environment, but even tech companies are frustrated by federal cuts that hamper regulatory processes. Paul Webster reports.
ALBAWABA - The Food and Drug Administration (FDA), which is responsible for protecting public health by ensuring the safety, efficacy, and security of d ...
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...
The issue is that banning all PFAS from medical devices would threaten care for the Americans who receive 300,000 newly ...
Patients who put their lives in the hands of healthcare institutions and personnel do so with an unmitigated amount of trust, ...
Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from ...
Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways.
This article explores the global regulatory landscape, examining how leading authorities in the U.S., EU, U.K., Canada, China ...
LAS VEGAS, NEVADA / ACCESS Newswire / April 29, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technolo ...
On the same occasion, director general of pharmacy and medical devices at the Ministry of Health, Lucia Rizka Andalusia, expressed her party's support for the development and adoption of AI in medical ...
The company recently closed an oversubscribed Series A investment round, with backers including the Western Development Commission, Enterprise Ireland and private medical device investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results